| abstract |
The present invention relates to a topical cosmetic or pharmaceutical composition consisting of a combination of three or four sunscreen agents, comprising: To achieve a critical wavelength> 370 nm, i. 5,6,5 ', 6'-tetraphenyl-3,3'-(1,4-phenylene) -bis [1,2,4] triazine, ii. 1,1 '-(1,4-piperazindiyl) bis [1- [2- [4- (diethylamino) -2-hydroxybenzoyl] phenyl] -methanone, iii. Less than 2% by weight of butyl methoxydibenzoylmethane (BMDBM), based on the total weight of the composition, iv. One or two UVA blockers selected from hexyl2- [4- (diethylamino) -2-hydroxybenzoyl] benzoate, 2,4-bis [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -6- (4-methoxyphenyl) -1,3,5-triazine = (BEMT), One or two blockers selected from UVB blockers, except octocrylene, PABA and ethylhexyl methoxycinnamate, and pharmaceutically or cosmetically acceptable excipients. |